200670.KS · 휴메딕스

South Korea · RS rating 13 · As of 2026-10-14

Price24,250.00 KRW
1-day change+0.4%
RS rating (overall / 1M / 3M / 12M)13 / 25 / 25 / 8
StageBasing
Composite / Minervini / CANSLIM score20 / 17 / 14
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-81.1%
Sales growth Q/Q+24.4%
Distance from 52-week high+55.8%
Market cap (USD)$210.2M
Open South Korea in the interactive screener